| Authors: |
Dumbrava EE; University of Texas M.D. Anderson Cancer Center, Houston., Shapiro GI; Dana-Farber Cancer Institute, Boston., Parikh AR; Massachusetts General Hospital, Boston., Johnson ML; Sarah Cannon Research Institute, Nashville., Tolcher AW; NEXT Oncology, Austin, Texas., Thompson JA; Fred Hutchinson Cancer Center, Seattle., El-Khoueiry AB; University of Southern California Norris Comprehensive Cancer Center, Los Angeles., Vandross AL; NEXT Oncology, Austin, Texas., Kummar S; Oregon Health and Science University Knight Cancer Institute, Portland., Shepard DR; Cleveland Clinic Foundation, Cleveland., LeDuke K; PMV Pharmaceuticals, Princeton, NJ., Sheehan L; PMV Pharmaceuticals, Princeton, NJ., Alland L; Leila Alland MD Consultancy, New York., Haque A; PMV Pharmaceuticals, Princeton, NJ., Jalota D; PMV Pharmaceuticals, Princeton, NJ., Fellous M; PMV Pharmaceuticals, Princeton, NJ., Schram AM; Memorial Sloan Kettering Cancer Center, New York. |
